Clinical trials: Pyoderma
Pyoderma Gangrenosum
A Study to Assess Adverse Events and Change in Disease State in Adult Participants Being Treated With Humira in Participants Diagnosed With Pyoderma Gangrenosum (PG)
Pyoderma Gangrenosum (PG) is a rapidly progressive disease and presents as painful, single or multiple lesions, with several clinical variants, in different locations, with a nonspecific histology, which makes the diagnosis…
- Trial name
- NCT04750213
- Where
- 46 sites in Japan
- Volunteers
- 60 people
- Sponsor
- AbbVie
Pyoderma Gangrenosum
A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum
The study will evaluate the long-term safety of gevokizumab in treating active PG ulcers
- Trial name
- NCT02318914
- Testing
- gevokizumab
- Where
- 40 sites in United States, Australia and 1 more
- Volunteers
- 15 people
- Sponsor
- XOMA (US) LLC
Ulcus Cruris, Ecthyma
Painless Sharp Wound Debridement With Lidocaine-23%-Tetra-caine-7% Gel Versus EMLA 5% Cream
In a single-blind, crossover, randomized, controlled trial with 40 participants we aim to demonstrate superior anaesthetic efficacy of lidocaine-23%-tetracaine-7% (IMP2) gel over EMLA 5% cream (IMP1) at comparable safety in sharp…
- Conditions
- Ulcus Cruris, Ecthyma, Ulcer, Leg, Ulcer Venous
- Trial name
- LIDOTETRA (NCT05890703)
- Testing
- IMP2 (lidocaine-23%-tetracaine-7% gel), IMP1 (EMLA 5% cream)
- Where
- Switzerland
- Volunteers
- 40 people
- Sponsor
- Juerg Hafner
Streptococcus Group A
Incidence of Group A Strep Pharyngitis in School Children in Fiji
The purpose of this study is to find out how often group A Streptococcus (GAS) occurs in school-age children of Central Fiji. This bacterium often causes pharyngitis (sore throat) and can also cause pyoderma (skin infection) or…
- Trial name
- NCT00284882
- Where
- Fiji
- Volunteers
- 1,000 people, healthy volunteers welcome
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)